United Kingdom

People: Qiagen NV (QGEN.N)

QGEN.N on New York Stock Exchange

18 Sep 2019
Change (% chg)

$-0.09 (-0.26%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Levine, Ross 

Prof. Dr. Ross L. Levine has served as Independent Member of the Supervisory Board of Qiagen N.V. since 2016. He is a physician-scientist focused on researching and treating blood and bone marrow cancers as the Laurence Joseph Dineen Chair in Leukemia Research, the Director of the Center for Hematologic Malignancies, and an Attending Physician at Memorial Sloan Kettering Cancer Center, as well as Professor of Medicine at Weill Cornell Medical College. He leads a research lab investigating genetics and targeted therapies in myeloid malignancies and is interested in application of next-generation sequencing technology in the practice of medicine in hematologic cancers. He trained in internal medicine at Massachusetts General Hospital and in hematology-oncology at the Dana-Farber Cancer Institute, earning board certification in these specialties. He received his M.D. from the Johns Hopkins University School of Medicine and his A.B. degree from Harvard College. Ross is Member of Science and Technology Committee of the Company.

Basic Compensation

Total Annual Compensation, USD 63,500
Restricted Stock Award, USD 9,866
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 73,366

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --